%PDF-1.6
%
1 0 obj
<>
endobj
2 0 obj
<>stream
Akiho Fukuda, Kohei Tahara, Yuuki Hane, Toshinobu Matsui, Sayaka Sasaoka, Haruna Hatahira, Yumi Motooka, Shiori Hasegawa, Misa Naganuma, Junko Abe, Satoshi Nakao, Hirofumi Takeuchi, Mitsuhiro Nakamura
Comparison of the adverse event profiles of conventional and liposomal formulations of doxorubicin using the FDA adverse event reporting system
www.plosone.org
www.plosone.org
endstream
endobj
3 0 obj
<>/XObject<>>>/CropBox[0 0 612 792]/MediaBox[0 0 612 792]/Parent 12 0 R/Annots 13 0 R/Contents 14 0 R/TrimBox[0 0 612 792]>>
endobj
13 0 obj
[15 0 R 16 0 R 17 0 R 18 0 R 19 0 R 20 0 R 21 0 R 22 0 R 23 0 R 24 0 R 25 0 R 26 0 R 27 0 R 28 0 R]
endobj
15 0 obj
<>/Border[0 0 0]/Dest(Rpone.0185654.ref001)>>
endobj
16 0 obj
<>/Border[0 0 0]/Dest(Rpone.0185654.ref001)>>
endobj
17 0 obj
<>/Border[0 0 0]/Dest(Rpone.0185654.ref002)>>
endobj
18 0 obj
<>/Border[0 0 0]/Dest(Rpone.0185654.ref003)>>
endobj
19 0 obj
<>/Border[0 0 0]/Dest(Rpone.0185654.ref004)>>
endobj
20 0 obj
<>/Border[0 0 0]/Dest(Rpone.0185654.ref005)>>
endobj
21 0 obj
<>/Border[0 0 0]/Dest(Rpone.0185654.ref006)>>
endobj
22 0 obj
<>/Border[0 0 0]/Dest(Rpone.0185654.ref007)>>
endobj
23 0 obj
<>/Border[0 0 0]/Dest(Rpone.0185654.ref008)>>
endobj
24 0 obj
<>/Border[0 0 0]/Dest(Rpone.0185654.ref009)>>
endobj
25 0 obj
<>/Border[0 0 0]/Dest(Rpone.0185654.ref010)>>
endobj
26 0 obj
<>/Border[0 0 0]/Dest(Rpone.0185654.ref011)>>
endobj
27 0 obj
<>/Border[0 0 0]/A 29 0 R>>
endobj
29 0 obj
<>
endobj
28 0 obj
<>/Border[0 0 0]/A 30 0 R>>
endobj
30 0 obj
<>
endobj
14 0 obj
[31 0 R 32 0 R 33 0 R 34 0 R 35 0 R 36 0 R 37 0 R 38 0 R 39 0 R 40 0 R 41 0 R 42 0 R 43 0 R 44 0 R]
endobj
31 0 obj
<>stream
q
0.83 0.64 0.02 0 k
257.4992 635.6409 m
262.2614 635.6409 l
h
f*
253.2472 596.6362 m
258.0094 596.6362 l
h
f*
249.5055 518.6268 m
254.2677 518.6268 l
h
f*
341.8016 492.6047 m
346.5638 492.6047 l
h
f*
348.8315 492.6047 m
353.537 492.6047 l
h
f*
269.0646 479.622 m
273.8268 479.622 l
h
f*
406.6583 453.6 m
411.4205 453.6 l
h
f*
413.6882 453.6 m
418.3937 453.6 l
h
f*
327.2882 401.6126 m
332.0504 401.6126 l
h
f*
334.2614 401.6126 m
339.0236 401.6126 l
h
f*
532.9701 336.6425 m
542.4945 336.6425 l
h
f*
544.7622 336.6425 m
554.2866 336.6425 l
h
f*
256.9323 224.9008 m
337.2661 224.9008 l
h
f*
0 g
1 j
1 J
0 w
11.9999 0 0 11.9999 200.0125 705.7133 cm
BT
/F2 1 Tf
1 TL
-0.0033 Tc
0 0 Td
(Introduction)Tj
ET
Q
q
1 j
1 J
0 w
10 0 0 10 200.0125 688.7055 cm
BT
/F6 1 Tf
1 TL
-0.004 Tc
0 0 Td
(Doxorubicin)Tj
5.3404 0 Td
(\(DOX\))Tj
3.033 0 Td
(is)Tj
0.8448 0 Td
(an)Tj
1.1962 0 Td
(anthracycline)Tj
5.6182 0 Td
(widely)Tj
2.8176 0 Td
(used)Tj
2.058 0 Td
(for)Tj
1.3833 0 Td
(the)Tj
1.4626 0 Td
(treatment)Tj
4.1329 0 Td
(of)Tj
1.0091 0 Td
(solid)Tj
2.126 0 Td
(and)Tj
1.7291 0 Td
(hematologi-)Tj
-32.7512 -1.2982 Td
(cal)Tj
1.3209 0 Td
(tumors)Tj
3.1067 0 Td
(such)Tj
2.058 0 Td
(as)Tj
1.0148 0 Td
(metastatic)Tj
4.2803 0 Td
(breast)Tj
2.6135 0 Td
(cancer,)Tj
3.0727 0 Td
(advanced)Tj
3.9912 0 Td
(ovarian)Tj
3.2371 0 Td
(cancer,)Tj
3.0671 0 Td
(acquired)Tj
3.702 0 Td
(immunodefi-)Tj
-31.4643 -1.3039 Td
(ciency)Tj
2.7609 0 Td
(syndrome-related)Tj
7.3076 0 Td
(Kaposi's)Tj
3.5547 0 Td
(sarcoma,)Tj
3.7984 0 Td
(and)Tj
1.7291 0 Td
(acute)Tj
2.3244 0 Td
(myeloblastic)Tj
5.21 0 Td
(leukemia.)Tj
4.0819 0 Td
(Conventional)Tj
-30.767 -1.2983 Td
(DOX)Tj
2.3527 0 Td
(administered)Tj
5.4935 0 Td
(as)Tj
1.0148 0 Td
(an)Tj
1.2019 0 Td
(intravenous)Tj
4.9606 0 Td
(bolus)Tj
2.3697 0 Td
(injection)Tj
3.7587 0 Td
(has)Tj
1.5421 0 Td
(been)Tj
2.126 0 Td
(shown)Tj
2.8459 0 Td
(to)Tj
1.0262 0 Td
(cure)Tj
1.9672 0 Td
(select)Tj
2.3924 0 Td
(cases)Tj
2.2224 0 Td
(for)Tj
-35.2741 -1.2983 Td
(over)Tj
1.9729 0 Td
(30)Tj
1.1735 0 Td
(years)Tj
2.262 0 Td
([)Tj
0.83 0.64 0.02 0 k
(1)Tj
0 g
(].)Tj
1.6044 0 Td
(However,)Tj
4.0762 0 Td
(due)Tj
1.7008 0 Td
(to)Tj
1.0261 0 Td
(the)Tj
1.4684 0 Td
(insufficient)Tj
4.7281 0 Td
(tissue)Tj
2.4548 0 Td
(preference)Tj
4.439 0 Td
(of)Tj
1.0148 0 Td
(conventional)Tj
5.4255 0 Td
(DOX,)Tj
2.5795 0 Td
(it)Tj
0.788 0 Td
(is)Tj
-36.714 -1.3039 Td
(distributed)Tj
4.5977 0 Td
(to)Tj
1.0205 0 Td
(the)Tj
1.474 0 Td
(entire)Tj
2.5512 0 Td
(body.)Tj
2.4434 0 Td
(Conventional)Tj
5.6636 0 Td
(DOX)Tj
2.3584 0 Td
(is)Tj
0.8447 0 Td
(toxic)Tj
2.1827 0 Td
(to)Tj
1.0261 0 Td
(most)Tj
2.2054 0 Td
(major)Tj
2.6078 0 Td
(organs)Tj
2.9083 0 Td
(and)Tj
1.7292 0 Td
(causes)Tj
2.7496 0 Td
(a)Tj
-36.3626 -1.2982 Td
(number)Tj
3.4185 0 Td
(of)Tj
1.0148 0 Td
(serious)Tj
3.0387 0 Td
(side)Tj
1.7972 0 Td
(effects)Tj
2.7269 0 Td
(including)Tj
4.0422 0 Td
(cardiotoxicity,)Tj
5.9527 0 Td
(hematological)Tj
5.8223 0 Td
(disorders,)Tj
4.1613 0 Td
(and)Tj
1.7291 0 Td
(myelo-)Tj
-33.7037 -1.2983 Td
(suppression)Tj
4.9832 0 Td
([)Tj
0.83 0.64 0.02 0 k
(1)Tj
0 g
(].)Tj
-3.787 -1.3039 Td
(The)Tj
1.7858 0 Td
(most)Tj
2.2053 0 Td
(challenging)Tj
4.8132 0 Td
(issue)Tj
2.16 0 Td
(in)Tj
1.0375 0 Td
(pharmaceutical)Tj
6.3666 0 Td
(engineering)Tj
4.9719 0 Td
(is)Tj
0.8504 0 Td
(the)Tj
1.4683 0 Td
(development)Tj
5.4085 0 Td
(of)Tj
1.0148 0 Td
(new)Tj
1.8765 0 Td
(drug)Tj
-35.155 -1.2983 Td
(delivery)Tj
3.3902 0 Td
(systems)Tj
3.2938 0 Td
(\(DDSs\),)Tj
3.4356 0 Td
(which)Tj
2.6532 0 Td
(enhance)Tj
3.5489 0 Td
(the)Tj
1.4684 0 Td
(therapeutic)Tj
4.7338 0 Td
(effects)Tj
2.7269 0 Td
(of)Tj
1.0148 0 Td
(drugs)Tj
2.4718 0 Td
(and)Tj
1.7291 0 Td
(reduce)Tj
2.9197 0 Td
(drug)Tj
2.109 0 Td
(tox-)Tj
-35.4952 -1.2983 Td
(icity)Tj
1.9275 0 Td
(to)Tj
1.0261 0 Td
(organs.)Tj
3.1351 0 Td
(These)Tj
2.5625 0 Td
(systems)Tj
3.2995 0 Td
(usually)Tj
3.0218 0 Td
(work)Tj
2.279 0 Td
(by)Tj
1.1792 0 Td
(either)Tj
2.5342 0 Td
(increasing)Tj
4.3256 0 Td
(drug)Tj
2.1146 0 Td
(concentration)Tj
5.8167 0 Td
(in)Tj
1.0375 0 Td
(tumor)Tj
-34.2593 -1.2982 Td
(cells)Tj
1.9218 0 Td
(or)Tj
1.0942 0 Td
(decreasing)Tj
4.4674 0 Td
(the)Tj
1.4683 0 Td
(exposure)Tj
3.8154 0 Td
(of)Tj
1.0148 0 Td
(normal)Tj
3.1464 0 Td
(tissues)Tj
2.8233 0 Td
(to)Tj
1.0262 0 Td
(drugs.)Tj
2.6929 0 Td
(Liposomes)Tj
4.524 0 Td
(are)Tj
1.4514 0 Td
(a)Tj
0.6519 0 Td
(novel)Tj
2.3981 0 Td
(type)Tj
1.9162 0 Td
(of)Tj
-34.4123 -1.3039 Td
(DDS.)Tj
2.3924 0 Td
(Currently,)Tj
4.3483 0 Td
(several)Tj
2.9367 0 Td
(liposomal)Tj
4.1272 0 Td
(formulations)Tj
5.3914 0 Td
(of)Tj
1.0148 0 Td
(DOX)Tj
2.3585 0 Td
(\(liposomal)Tj
4.4673 0 Td
(DOX\))Tj
2.6929 0 Td
(are)Tj
1.4514 0 Td
(available)Tj
3.6623 0 Td
(for)Tj
-34.8432 -1.2983 Td
(clinical)Tj
3.0727 0 Td
(use)Tj
1.5364 0 Td
([)Tj
0.83 0.64 0.02 0 k
(2)Tj
0 g
(].)Tj
-3.4129 -1.2983 Td
(These)Tj
2.5681 0 Td
(liposomal)Tj
4.1273 0 Td
(DOX)Tj
2.3527 0 Td
(preparations)Tj
5.2724 0 Td
(are)Tj
1.4513 0 Td
(divided)Tj
3.2145 0 Td
(into)Tj
1.8425 0 Td
(two)Tj
1.7065 0 Td
(categories:)Tj
4.422 0 Td
(PEGylated)Tj
4.4447 0 Td
(liposome)Tj
-32.5982 -1.3039 Td
(DOX)Tj
2.3527 0 Td
(\(PEGylated-liposome)Tj
8.7873 0 Td
(DOX\))Tj
2.6986 0 Td
([)Tj
0.83 0.64 0.02 0 k
(3)Tj
0 g
(,)Tj
0.83 0.64 0.02 0 k
(4)Tj
0 g
(])Tj
2.075 0 Td
(and)Tj
1.7291 0 Td
(non-PEGylated)Tj
6.4062 0 Td
(liposome)Tj
3.8665 0 Td
(DOX)Tj
2.3584 0 Td
(\(non-PEGylated-)Tj
-30.2738 -1.2982 Td
(liposome)Tj
3.8664 0 Td
(DOX\))Tj
2.6985 0 Td
([)Tj
0.83 0.64 0.02 0 k
(5)Tj
0 g
(].)Tj
1.5988 0 Td
(Liposomal)Tj
4.4163 0 Td
(formulations)Tj
5.3972 0 Td
(containing)Tj
4.5297 0 Td
(poly)Tj
1.9445 0 Td
(\(ethylene)Tj
3.9062 0 Td
(glycol\)\(PEG\)modi-)Tj
-28.3576 -1.2983 Td
(fied,)Tj
1.9502 0 Td
(that)Tj
1.7801 0 Td
(is)Tj
0.8447 0 Td
(PEGylated,)Tj
5.4595 0 Td
(lipids)Tj
2.4095 0 Td
(exhibit)Tj
2.9707 0 Td
(an)Tj
1.2075 0 Td
(increased)Tj
3.9968 0 Td
(circulation)Tj
4.5354 0 Td
(time)Tj
2.0296 0 Td
(because)Tj
3.3165 0 Td
(of)Tj
1.0148 0 Td
(a)Tj
0.6577 0 Td
(reduced)Tj
3.4412 0 Td
(ten-)Tj
-35.6142 -1.3039 Td
(dency)Tj
2.5965 0 Td
(to)Tj
1.0261 0 Td
(aggregate)Tj
3.9968 0 Td
(following)Tj
3.9798 0 Td
(intravenous)Tj
4.9663 0 Td
(injection)Tj
3.7587 0 Td
([)Tj
0.83 0.64 0.02 0 k
(6)Tj
0 g
(,)Tj
0.83 0.64 0.02 0 k
(7)Tj
0 g
(].)Tj
2.3017 0 Td
(Several)Tj
3.0501 0 Td
(studies)Tj
2.982 0 Td
(have)Tj
2.0636 0 Td
(reported)Tj
3.6567 0 Td
(that)Tj
-34.3783 -1.2983 Td
(patients)Tj
3.3675 0 Td
(treated)Tj
2.9934 0 Td
(with)Tj
2.0012 0 Td
(liposomal)Tj
4.1216 0 Td
(DOX)Tj
2.3584 0 Td
(demonstrate)Tj
5.2327 0 Td
(specific)Tj
3.1918 0 Td
(mucocutaneous)Tj
6.548 0 Td
(adverse)Tj
3.2144 0 Td
(events)Tj
-33.029 -1.2983 Td
(\(AEs\))Tj
2.5114 0 Td
(such)Tj
2.0636 0 Td
(as)Tj
1.0148 0 Td
(palmar-plantar)Tj
6.2419 0 Td
(erythrodysesthesia)Tj
7.6138 0 Td
(\(PPE\),)Tj
2.8119 0 Td
(which)Tj
2.6476 0 Td
(is)Tj
0.8504 0 Td
(also)Tj
1.7688 0 Td
(known)Tj
3.0047 0 Td
(as)Tj
1.0148 0 Td
(hand-foot)Tj
4.2066 0 Td
(syn-)Tj
-35.7503 -1.3039 Td
(drome.)Tj
3.0954 0 Td
(This)Tj
1.9842 0 Td
(AE)Tj
1.474 0 Td
(limits)Tj
2.4775 0 Td
(the)Tj
1.474 0 Td
(feasibility)Tj
4.0308 0 Td
(of)Tj
1.0148 0 Td
(antitumor)Tj
4.2916 0 Td
(chemotherapy)Tj
5.9471 0 Td
(with)Tj
2.0012 0 Td
(DOX)Tj
2.3528 0 Td
(and)Tj
1.7291 0 Td
(negatively)Tj
-31.8725 -1.2982 Td
(affects)Tj
2.7325 0 Td
(a)Tj
0.6577 0 Td
(patient's)Tj
3.5829 0 Td
(quality)Tj
2.9537 0 Td
(of)Tj
1.0148 0 Td
(life)Tj
1.4457 0 Td
([)Tj
0.83 0.64 0.02 0 k
(8)Tj
0 g
(,)Tj
0.83 0.64 0.02 0 k
(9)Tj
0 g
(].)Tj
-11.1911 -1.2983 Td
(Spontaneous)Tj
5.3687 0 Td
(reporting)Tj
3.9912 0 Td
(systems)Tj
3.2995 0 Td
(\(SRSs\),)Tj
3.0614 0 Td
(wherein)Tj
3.4639 0 Td
(clinicians)Tj
4.0082 0 Td
(report)Tj
2.7099 0 Td
(their)Tj
2.1033 0 Td
(concerns)Tj
3.8267 0 Td
(about)Tj
-33.029 -1.2983 Td
(potential)Tj
3.7587 0 Td
(drug-induced)Tj
5.7089 0 Td
(AEs)Tj
1.8368 0 Td
(during)Tj
2.9254 0 Td
(their)Tj
2.1089 0 Td
(daily)Tj
2.1487 0 Td
(diagnostic)Tj
4.32 0 Td
(assessments)Tj
4.9719 0 Td
(of)Tj
1.0148 0 Td
(patients,)Tj
3.5943 0 Td
(are)Tj
1.4457 0 Td
(useful)Tj
-33.8341 -1.3039 Td
(for)Tj
1.3832 0 Td
(the)Tj
1.4741 0 Td
(detection)Tj
3.9344 0 Td
(of)Tj
1.0148 0 Td
(rare)Tj
1.8198 0 Td
(and)Tj
1.7292 0 Td
(severe)Tj
2.6815 0 Td
(AEs.)Tj
2.058 0 Td
(The)Tj
1.7801 0 Td
(US)Tj
1.4343 0 Td
(Food)Tj
2.2904 0 Td
(and)Tj
1.7291 0 Td
(Drug)Tj
2.3188 0 Td
(Administration)Tj
6.4232 0 Td
(\(FDA\))Tj
-32.0709 -1.2983 Td
(Adverse)Tj
3.4639 0 Td
(Event)Tj
2.5171 0 Td
(Reporting)Tj
4.2406 0 Td
(System)Tj
3.0501 0 Td
(\(FAERS\))Tj
3.7814 0 Td
(is)Tj
0.8447 0 Td
(the)Tj
1.4683 0 Td
(largest)Tj
2.8233 0 Td
(SRS)Tj
1.7915 0 Td
(in)Tj
1.0375 0 Td
(the)Tj
1.4683 0 Td
(world.)Tj
2.7836 0 Td
(It)Tj
0.8561 0 Td
(is)Tj
0.8504 0 Td
(recognized)Tj
4.5864 0 Td
(as)Tj
-35.5632 -1.2982 Td
(the)Tj
1.4683 0 Td
(primary)Tj
3.4582 0 Td
(tool)Tj
1.7745 0 Td
(for)Tj
1.389 0 Td
(pharmacovigilance)Tj
7.7839 0 Td
(that)Tj
1.7744 0 Td
(reflects)Tj
3.0558 0 Td
(the)Tj
1.474 0 Td
(realities)Tj
3.3108 0 Td
(of)Tj
1.0148 0 Td
(clinical)Tj
3.0728 0 Td
(practice)Tj
3.3788 0 Td
([)Tj
0.83 0.64 0.02 0 k
(10)Tj
0 g
(,)Tj
0.83 0.64 0.02 0 k
(11)Tj
0 g
(].)Tj
-31.7591 -1.3039 Td
(The)Tj
1.7858 0 Td
(aim)Tj
1.7404 0 Td
(of)Tj
1.0148 0 Td
(this)Tj
1.6725 0 Td
(study)Tj
2.3924 0 Td
(was)Tj
1.6951 0 Td
(to)Tj
1.0261 0 Td
(assess)Tj
2.5229 0 Td
(the)Tj
1.4683 0 Td
(AE)Tj
1.474 0 Td
(profiles)Tj
3.2031 0 Td
(of)Tj
1.0148 0 Td
(conventional)Tj
5.4255 0 Td
(DOX)Tj
2.3584 0 Td
(and)Tj
1.7291 0 Td
(liposomal)Tj
-31.7194 -1.2983 Td
(DOX.)Tj
2.5795 0 Td
(We)Tj
1.61 0 Td
(also)Tj
1.7688 0 Td
(compared)Tj
4.2406 0 Td
(the)Tj
1.474 0 Td
(results)Tj
2.8063 0 Td
(obtained)Tj
3.7361 0 Td
(for)Tj
1.3833 0 Td
(PEGylated-liposome)Tj
8.4472 0 Td
(DOX)Tj
2.3584 0 Td
(with)Tj
1.9955 0 Td
(those)Tj
-32.3997 -1.2983 Td
(obtained)Tj
3.7303 0 Td
(for)Tj
1.389 0 Td
(non-PEGylated-liposome)Tj
10.4031 0 Td
(DOX.)Tj
2.5795 0 Td
(To)Tj
1.3379 0 Td
(the)Tj
1.4684 0 Td
(best)Tj
1.8085 0 Td
(of)Tj
1.0148 0 Td
(our)Tj
1.627 0 Td
(knowledge,)Tj
4.7679 0 Td
(this)Tj
1.6724 0 Td
(is)Tj
0.8504 0 Td
(the)Tj
1.4683 0 Td
(first)Tj
-34.1175 -1.3039 Td
(study)Tj
2.3867 0 Td
(to)Tj
1.0261 0 Td
(evaluate)Tj
3.464 0 Td
(the)Tj
1.4683 0 Td
(effects)Tj
2.7269 0 Td
(of)Tj
1.0148 0 Td
(liposomal)Tj
4.1216 0 Td
(formulations)Tj
5.3971 0 Td
(of)Tj
1.0148 0 Td
(DOX)Tj
2.3584 0 Td
(using)Tj
2.3867 0 Td
(the)Tj
1.4684 0 Td
(FAERS)Tj
3.1011 0 Td
(database.)Tj
ET
Q
q
1 j
1 J
0 w
11.9999 0 0 11.9999 200.0125 256.0251 cm
BT
/F2 1 Tf
1 TL
-0.0033 Tc
0 0 Td
(Materials)Tj
4.5071 0 Td
(and)Tj
1.989 0 Td
(methods)Tj
ET
Q
q
1 j
1 J
0 w
10 0 0 10 200.0125 239.0173 cm
BT
/F6 1 Tf
1 TL
-0.004 Tc
0 0 Td
(Data)Tj
2.1203 0 Td
(from)Tj
2.2053 0 Td
(January)Tj
3.3222 0 Td
(2004)Tj
2.1203 0 Td
(to)Tj
1.0261 0 Td
(December)Tj
4.3483 0 Td
(2015)Tj
2.1203 0 Td
(in)Tj
1.0375 0 Td
(the)Tj
1.4683 0 Td
(FAERS)Tj
3.1011 0 Td
(database)Tj
3.6397 0 Td
(were)Tj
2.1203 0 Td
(downloaded)Tj
5.1533 0 Td
(from)Tj
2.2054 0 Td
(the)Tj
-35.9884 -1.3039 Td
(FDA)Tj
2.1656 0 Td
(website)Tj
3.1861 0 Td
(\()Tj
0.83 0.64 0.02 0 k
(http://www.fda.gov/)Tj
0 g
(\).)Tj
9.1615 0 Td
(The)Tj
1.7802 0 Td
(FAERS)Tj
3.1011 0 Td
(database)Tj
3.6396 0 Td
(structure)Tj
3.8211 0 Td
(complies)Tj
3.7871 0 Td
(with)Tj
1.9956 0 Td
(the)Tj
1.4683 0 Td
(interna-)Tj
-34.1062 -1.2982 Td
(tional)Tj
2.5171 0 Td
(safety)Tj
2.4831 0 Td
(reporting)Tj
3.9912 0 Td
(guidelines)Tj
4.2746 0 Td
(\(International)Tj
5.828 0 Td
(Council)Tj
3.4016 0 Td
(on)Tj
1.2755 0 Td
(Harmonization,)Tj
6.6274 0 Td
(E2B\).)Tj
2.4094 0 Td
(We)Tj
1.6101 0 Td
(then)Tj
-34.418 -1.2983 Td
(integrated)Tj
4.2746 0 Td
(the)Tj
1.474 0 Td
(information)Tj
5.074 0 Td
(obtained)Tj
3.7303 0 Td
(into)Tj
1.8425 0 Td
(a)Tj
0.6577 0 Td
(relational)Tj
3.9911 0 Td
(database)Tj
3.6397 0 Td
(using)Tj
2.3924 0 Td
(FileMaker)Tj
4.303 0 Td
(Pro)Tj
1.6554 0 Td
(13)Tj
1.1735 0 Td
(software)Tj
-34.2082 -1.3039 Td
(\(FileMaker,)Tj
4.8642 0 Td
(Inc.,)Tj
1.9842 0 Td
(Santa)Tj
2.4094 0 Td
(Clara,)Tj
2.5966 0 Td
(CA,)Tj
1.7914 0 Td
(USA\).)Tj
2.6816 0 Td
(Next,)Tj
2.3698 0 Td
(we)Tj
1.3266 0 Td
(followed)Tj
3.651 0 Td
(the)Tj
1.4683 0 Td
(recommendation)Tj
7.1376 0 Td
(by)Tj
1.1849 0 Td
(the)Tj
1.4683 0 Td
(FDA)Tj
-34.9339 -1.2983 Td
(to)Tj
1.0261 0 Td
(use)Tj
1.5307 0 Td
(the)Tj
1.4683 0 Td
(most)Tj
2.2054 0 Td
(recent)Tj
2.7099 0 Td
(case)Tj
1.8595 0 Td
(numbers)Tj
3.7814 0 Td
(to)Tj
1.0261 0 Td
(identify)Tj
3.2938 0 Td
(duplicate)Tj
3.8835 0 Td
(reports)Tj
3.0727 0 Td
(for)Tj
1.3833 0 Td
(the)Tj
1.474 0 Td
(same)Tj
2.2564 0 Td
(patient)Tj
3.0047 0 Td
(and)Tj
-33.9758 -1.2982 Td
(excluded)Tj
3.7813 0 Td
(such)Tj
2.0637 0 Td
(data)Tj
1.9105 0 Td
(from)Tj
2.2053 0 Td
(the)Tj
1.474 0 Td
(analysis.)Tj
-10.2386 -1.2983 Td
(Data)Tj
2.1259 0 Td
(on)Tj
1.2756 0 Td
(conventional)Tj
5.4255 0 Td
(DOX)Tj
2.3584 0 Td
(\(Adriamycin)Tj
ET
Q
q
1 j
1 J
0 w
7.4999 0 0 6.6659 375.1937 152.4472 cm
BT
/F11 1 Tf
1 TL
-0.0053 Tc
0 0 Td
(1)Tj
ET
Q
q
1 j
1 J
0 w
10 0 0 10 382.6771 148.0251 cm
BT
/F6 1 Tf
1 TL
-0.004 Tc
0 0 Td
(\),)Tj
0.7823 0 Td
(PEGylated-liposome)Tj
8.4472 0 Td
(DOX)Tj
2.3584 0 Td
([Doxil)Tj
ET
Q
q
1 j
1 J
0 w
7.4999 0 0 6.6659 524.1826 152.4472 cm
BT
/F11 1 Tf
1 TL
-0.0053 Tc
0 0 Td
(1)Tj
ET
Q
q
1 j
1 J
0 w
10 0 0 10 533.8204 148.0251 cm
BT
/F6 1 Tf
1 TL
-0.004 Tc
0 0 Td
(\(Janssen)Tj
-33.3805 -1.3039 Td
(Pharmaceuticals,)Tj
6.9958 0 Td
(Inc.,)Tj
1.9843 0 Td
(Beerse,)Tj
3.0274 0 Td
(Belgium\),)Tj
4.1102 0 Td
(Caelyx)Tj
ET
Q
q
1 j
1 J
0 w
7.4999 0 0 6.6659 388.0629 139.4645 cm
BT
/F11 1 Tf
1 TL
-0.0053 Tc
0 0 Td
(1)Tj
ET
Q
q
1 j
1 J
0 w
10 0 0 10 397.7574 134.9858 cm
BT
/F6 1 Tf
1 TL
-0.004 Tc
0 0 Td
(\(Janssen)Tj
3.5659 0 Td
(Pharmaceuticals,)Tj
6.9959 0 Td
(Inc.\),)Tj
2.3244 0 Td
(and)Tj
1.7291 0 Td
(Lipo-)Tj
-34.3896 -1.2982 Td
(Dox)Tj
ET
Q
q
1 j
1 J
0 w
7.4999 0 0 6.6659 217.0771 126.4251 cm
BT
/F11 1 Tf
1 TL
-0.0053 Tc
0 0 Td
(1)Tj
ET
Q
q
1 j
1 J
0 w
10 0 0 10 226.7716 122.0031 cm
BT
/F6 1 Tf
1 TL
-0.004 Tc
0 0 Td
(\(Sun)Tj
2.1089 0 Td
(Pharmaceutical)Tj
6.4119 0 Td
(Industries)Tj
4.2463 0 Td
(Ltd.,)Tj
2.0353 0 Td
(Mumbai,)Tj
3.8891 0 Td
(India\)],)Tj
3.2485 0 Td
(and)Tj
1.7291 0 Td
(non-PEGylated-liposome)Tj
-26.3449 -1.2982 Td
(DOX)Tj
2.3527 0 Td
(\(Myocet)Tj
ET
Q
q
1 j
1 J
0 w
7.4999 0 0 6.6659 256.9322 113.4425 cm
BT
/F11 1 Tf
1 TL
-0.0053 Tc
0 0 Td
(1)Tj
ET
Q
q
1 j
1 J
0 w
10 0 0 10 264.4157 109.0204 cm
BT
/F6 1 Tf
1 TL
-0.004 Tc
0 0 Td
(;)Tj
0.4478 0 Td
(Teva)Tj
2.143 0 Td
(Pharmaceutical)Tj
6.4063 0 Td
(Industries)Tj
4.2462 0 Td
(Ltd.,)Tj
2.0353 0 Td
(Petah)Tj
2.4661 0 Td
(Tikva,)Tj
2.7043 0 Td
(Israel\))Tj
2.7382 0 Td
(formulations)Tj
5.3971 0 Td
(were)Tj
-35.0245 -1.3039 Td
(analyzed.)Tj
3.9231 0 Td
(Doxil)Tj
ET
Q
q
1 j
1 J
0 w
7.4999 0 0 6.6659 261.4677 100.4598 cm
BT
/F11 1 Tf
1 TL
-0.0053 Tc
0 0 Td
(1)Tj
ET
Q
q
1 j
1 J
0 w
10 0 0 10 271.1622 95.9811 cm
BT
/F6 1 Tf
1 TL
-0.004 Tc
0 0 Td
(and)Tj
1.7291 0 Td
(Caelyx)Tj
ET
Q
q
1 j
1 J
0 w
7.4999 0 0 6.6659 315.3259 100.4598 cm
BT
/F11 1 Tf
1 TL
-0.0053 Tc
0 0 Td
(1)Tj
ET
Q
q
1 j
1 J
0 w
10 0 0 10 325.0204 95.9811 cm
BT
/F6 1 Tf
1 TL
-0.004 Tc
0 0 Td
(are)Tj
1.4456 0 Td
(same)Tj
2.2564 0 Td
(liposomal)Tj
4.1272 0 Td
(DOX)Tj
2.3584 0 Td
(formulation.)Tj
5.2554 0 Td
(Drugs)Tj
2.6816 0 Td
(in)Tj
1.0374 0 Td
(the)Tj
1.4684 0 Td
(FAERS)Tj
-33.1311 -1.2982 Td
(database)Tj
3.6397 0 Td
(are)Tj
1.4457 0 Td
(registered)Tj
4.1555 0 Td
(arbitrarily;)Tj
4.4673 0 Td
(for)Tj
1.3833 0 Td
(example,)Tj
3.7757 0 Td
(they)Tj
1.9276 0 Td
(may)Tj
1.9275 0 Td
(be)Tj
1.1509 0 Td
(registered)Tj
4.1499 0 Td
(as)Tj
1.0148 0 Td
(generic)Tj
3.1407 0 Td
(or)Tj
1.0999 0 Td
(brand)Tj
ET
Q
q
1 j
1 J
0 w
576 737.1 m
36 737.1 l
36 737.6 l
576 737.6 l
f*
36 741.2598 107.1496 23.6976 re
W* n
q
107.0929 0 0 23.6409 36 741.3165 cm
q
/I0 Do
Q
Q
Q
q
0 0 612 792 re
W* n
1 j
1 J
0 w
7.9999 0 0 7.9999 239.1307 745.7952 cm
BT
/F0 1 Tf
1 TL
-0.005 Tc
0 0 Td
(Adverse)Tj
3.8268 0 Td
(event)Tj
2.6291 0 Td
(profiles)Tj
3.3733 0 Td
(of)Tj
1.0417 0 Td
(convention)Tj
4.7481 0 Td
(al)Tj
0.9779 0 Td
(and)Tj
1.8567 0 Td
(liposomal)Tj
4.3583 0 Td
(formulations)Tj
5.5702 0 Td
(of)Tj
1.0417 0 Td
(doxorubic)Tj
4.252 0 Td
(in)Tj
0.9851 0 Td
(using)Tj
2.5582 0 Td
(the)Tj
1.5875 0 Td
(FAERS)Tj
ET
Q
q
1 j
1 J
0 w
36 48.0002 m
576 48.0002 l
576 47.5002 l
36 47.5002 l
f*
0.83 0.64 0.02 0 k
81.5811 34.9228 m
237.8835 34.9228 l
h
f*
0 g
7.9999 0 0 7.9999 36 36 cm
BT
/F0 1 Tf
1 TL
-0.005 Tc
0 0 Td
(PLOS)Tj
2.8559 0 Td
(ONE)Tj
2.3669 0 Td
(|)Tj
0.83 0.64 0.02 0 k
0.4748 0 Td
(https://doi.or)Tj
5.4142 0 Td
(g/10.137)Tj
3.8198 0 Td
(1/journal.po)Tj
5.1236 0 Td
(ne.01856)Tj
4.089 0 Td
(54)Tj
0 g
2.0906 0 Td
(September)Tj
5.0386 0 Td
(27,)Tj
1.5874 0 Td
(2017)Tj
32.2798 0 Td
(2)Tj
0.7654 0 Td
(/)Tj
0.496 0 Td
(11)Tj
/F9 1 Tf
-0.025 Tc
-66.402 84.0904 Td
(manuscript.)Tj
4.6417 0 Td
(There)Tj
2.3103 0 Td
(was)Tj
1.7079 0 Td
(no)Tj
1.1622 0 Td
(additional)Tj
3.7913 0 Td
(external)Tj
-13.6134 -1.3748 Td
(funding)Tj
3.033 0 Td
(received)Tj
3.3024 0 Td
(for)Tj
1.2544 0 Td
(the)Tj
1.3748 0 Td
(study.)Tj
/F8 1 Tf
-8.9646 -2.126 Td
(Competing)Tj
4.3795 0 Td
(interests)Tj
3.3307 0 Td
(:)Tj
/F9 1 Tf
0.4819 0 Td
(JA)Tj
1.1623 0 Td
(is)Tj
0.8362 0 Td
(an)Tj
1.1126 0 Td
(employee)Tj
3.7984 0 Td
(of)Tj
0.9497 0 Td
(Medical)Tj
-16.0513 -1.3749 Td
(Database.)Tj
3.8693 0 Td
(There)Tj
2.3173 0 Td
(are)Tj
1.3677 0 Td
(no)Tj
1.1693 0 Td
(patents,)Tj
3.1678 0 Td
(products)Tj
3.515 0 Td
(in)Tj
-15.4064 -1.3748 Td
(developm)Tj
3.6283 0 Td
(ent)Tj
1.3748 0 Td
(or)Tj
0.9993 0 Td
(marketed)Tj
3.6992 0 Td
(products)Tj
3.515 0 Td
(to)Tj
0.9496 0 Td
(declare.)Tj
3.104 0 Td
(This)Tj
-17.2702 -1.3748 Td
(does)Tj
2.0126 0 Td
(not)Tj
1.4173 0 Td
(alter)Tj
1.8213 0 Td
(our)Tj
1.474 0 Td
(adherence)Tj
4.0536 0 Td
(to)Tj
0.9496 0 Td
(PLOS)Tj
2.3315 0 Td
(ONE)Tj
1.8709 0 Td
(policies)Tj
-15.9308 -1.3748 Td
(on)Tj
1.1693 0 Td
(sharing)Tj
2.9834 0 Td
(data)Tj
1.7859 0 Td
(and)Tj
1.5945 0 Td
(material)Tj
ET
endstream
endobj
32 0 obj
<>stream
endstream
endobj
33 0 obj
<>stream
endstream
endobj
34 0 obj
<>stream
endstream
endobj
35 0 obj
<>stream
endstream
endobj
36 0 obj
<>stream
endstream
endobj
37 0 obj
<>stream
endstream
endobj
38 0 obj
<>stream
endstream
endobj
39 0 obj
<>stream
endstream
endobj
40 0 obj
<>stream
endstream
endobj
41 0 obj
<>stream
endstream
endobj
42 0 obj
<>stream
endstream
endobj
43 0 obj
<>stream
endstream
endobj
44 0 obj
<>stream
BT
10.4953 75.0903 Td
(s.)Tj
ET
Q
endstream
endobj
45 0 obj
<>/XObject<>>>/CropBox[0 0 612 792]/MediaBox[0 0 612 792]/Parent 12 0 R/Annots 49 0 R/Contents 50 0 R/TrimBox[0 0 612 792]>>
endobj
47 0 obj
<>
endobj
51 0 obj
<>
endobj
52 0 obj
<>stream
%!PS-AdobeFont-1.0
11 dict begin
/FontName /TeX_CM_Maths_Symbols def
/FontType 1 def
/FontBBox {-20 -958 1114 770} readonly def
/FontMatrix [0.001 0 0 0.001 0 0] readonly def
/PaintType 0 def
/FontInfo 8 dict dup begin
/FullName (TeX_CM_Maths_Symbols) readonly def
/BaseFontName (TeX_CM_Maths_Symbols) def
end def
/Encoding 256 array
0 1 255 {1 index exch /.notdef put} for
dup 0 /C0 put
dup 1 /C1 put
dup 2 /C2 put
dup 3 /C3 put
dup 4 /C4 put
dup 5 /C5 put
dup 6 /C6 put
dup 7 /C7 put
dup 8 /C8 put
dup 9 /C9 put
dup 10 /C10 put
dup 11 /C11 put
dup 12 /C12 put
dup 13 /C13 put
dup 14 /C14 put
dup 15 /C15 put
dup 16 /C16 put
dup 17 /C17 put
dup 18 /C18 put
dup 19 /C19 put
dup 20 /C20 put
dup 21 /C21 put
dup 22 /C22 put
dup 23 /C23 put
dup 24 /C24 put
dup 25 /C25 put
dup 26 /C26 put
dup 27 /C27 put
dup 28 /C28 put
dup 29 /C29 put
dup 30 /C30 put
dup 31 /C31 put
dup 32 /space put
dup 33 /exclam put
dup 34 /quotedbl put
dup 35 /numbersign put
dup 36 /dollar put
dup 37 /percent put
dup 38 /ampersand put
dup 39 /quoteright put
dup 40 /parenleft put
dup 41 /parenright put
dup 42 /asterisk put
dup 43 /plus put
dup 44 /comma put
dup 45 /hyphen put
dup 46 /period put
dup 47 /slash put
dup 48 /zero put
dup 49 /one put
dup 50 /two put
dup 51 /three put
dup 52 /four put
dup 53 /five put
dup 54 /six put
dup 55 /seven put
dup 56 /eight put
dup 57 /nine put
dup 58 /colon put
dup 59 /semicolon put
dup 60 /less put
dup 61 /equal put
dup 62 /greater put
dup 63 /question put
dup 64 /at put
dup 65 /A put
dup 66 /B put
dup 67 /C put
dup 68 /D put
dup 69 /E put
dup 70 /F put
dup 71 /G put
dup 72 /H put
dup 73 /I put
dup 74 /J put
dup 75 /K put
dup 76 /L put
dup 77 /M put
dup 78 /N put
dup 79 /O put
dup 80 /P put
dup 81 /Q put
dup 82 /R put
dup 83 /S put
dup 84 /T put
dup 85 /U put
dup 86 /V put
dup 87 /W put
dup 88 /X put
dup 89 /Y put
dup 90 /Z put
dup 91 /bracketleft put
dup 92 /backslash put
dup 93 /bracketright put
dup 94 /asciicircum put
dup 95 /underscore put
dup 96 /quoteleft put
dup 97 /a put
dup 98 /b put
dup 99 /c put
dup 100 /d put
dup 101 /e put
dup 102 /f put
dup 103 /g put
dup 104 /h put
dup 105 /i put
dup 106 /j put
dup 107 /k put
dup 108 /l put
dup 109 /m put
dup 110 /n put
dup 111 /o put
dup 112 /p put
dup 113 /q put
dup 114 /r put
dup 115 /s put
dup 116 /t put
dup 117 /u put
dup 118 /v put
dup 119 /w put
dup 120 /x put
dup 121 /y put
dup 122 /z put
dup 123 /braceleft put
dup 124 /bar put
dup 125 /braceright put
dup 126 /asciitilde put
dup 127 /Euro put
dup 128 /ff put
dup 129 /ffi put
dup 130 /ffl put
dup 131 /C131 put
dup 132 /Eth put
dup 133 /eth put
dup 134 /Thorn put
dup 135 /thorn put
dup 136 /onequarter put
dup 137 /onehalf put
dup 138 /C138 put
readonly def
currentdict end
currentfile eexec
M#1H5 J6o\&rtS(#v\0\V7Fe༙OYx5-cY9^%Y6
(efIOldN"wȰ;)UƽoFg/rvV$JS8_oc@
o9-eGJp}[Do]mN=4*{ܯq=eU^t6¤(HwK7X7
Mr:E%]3<Ӝ$wrAQ4ADt%̏>E hAجm*pu@>#6aZi}NRmƼ%
,OgX' EX?ڞ\#JEG<IXS}Eh[ş8ї48ٶ.w4bJ?_nfulqD?둓\C%+' { L9K7isW+ӕ(6oɧVҺlS;5K
Z%.oQՕW*9Qk_S+B-}%lYC@WP0b\KKdi>t,n_S[ '9`-z+cڦEb#c@;yɸoAT O_H~i -6ϰ豟Ae&BF+
wNX!=hhUF8(hZ6pgJc m'9dx*^wXc
գ<.쯶c ln)/LvXY2jbF:ȸ3'>\Ȥmzj,!:ZK' (q/ -&&S ؤ-bm KQSxLGu `D3yԱKaVMU§ %iq5%s 2SdR#ho45H.4TdՊa<K>BqG- Ao, (e&F2gG`z8*༠&
x#B
B;8!93~T/ \>nLazCSKm~,!_<ӾX@X@N2vEt בFmBYa wRG[i;+oM+%(8 jԀlIW>t